BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6056665)

  • 1. [Factor 13 (fibrin stabilizing factor) in the full-term newborn infant and in the suckling].
    Violante N; Paganetti G; Lattanzi E; Schettini F
    Boll Soc Ital Biol Sper; 1967 May; 43(10):535-7. PubMed ID: 6056665
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factor XI (plasma thromboplastin antecedent) in the full-term newborn infant and the suckling].
    Schettini F; Violante N; Lattanzi E; Paganetti G
    Boll Soc Ital Biol Sper; 1967 May; 43(10):532-5. PubMed ID: 6056664
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children].
    Zuch A; Rudobielska M; Zwierzowa W; Jurgielewicz E; Buluk K
    Pediatr Pol; 1972 Oct; 47(10):1197-203. PubMed ID: 5085405
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis, fibrinogen and factor 13 in new born infants.
    Fisher S; Schwartz M; Gottlieb A; Yoseph NB; Shapiro S
    Thromb Diath Haemorrh; 1968 Dec; 20(3):542-7. PubMed ID: 5751637
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma fibrin-stabilizing factor activity in acquired disease.
    Walls WD; Losowsky MS
    Br J Haematol; 1968 Sep; 15(3):327. PubMed ID: 5681498
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebro-meningeal hemorrhage of a newborn revealing a congenital factor 13 deficiency (fibrin stabilizing factor. FSF)].
    Schaison G; Delobel J; Sultan Y; Crépinet J; Caen J; Bernard J
    Nouv Rev Fr Hematol; 1969; 9(2):287-9. PubMed ID: 4239788
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infant.
    Henriksson P; Hedner U; Nilsson IM; Boehm J; Robertson B; Lorand L
    Pediatr Res; 1974 Sep; 8(9):789-91. PubMed ID: 4413463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activity of the fibrin stabilizing factor in the neonatal period].
    Chipail A; Schneer JH; Schrotter L; Tacu C
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(1):29-34. PubMed ID: 5438928
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibrin-stabilizing factor. A decade of progress.
    Mandel EE
    Ann Clin Lab Sci (1971); 1971; 1(1):92-9. PubMed ID: 4949766
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congenital absence of the fibrin-stabilizing factor. (Factor 13)].
    Ciepielewska D; Lopaciuk S
    Pediatr Pol; 1970 Jul; 45(7):829-32. PubMed ID: 5449789
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proportion of activity of the stabilizing factor of the fibrin (factor 13) during labor and puerperium].
    Joana Geraldes M; Macedo Dória J
    Rev Clin Inst Matern Lisb; 1967; 18(70):183-6. PubMed ID: 5302212
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of the contact substance in thromboplastin formation in the full-term newborn infant].
    Schettini F; Wierdis T; Lattanzi E; Violante N; Zimbalatti F
    Boll Soc Ital Biol Sper; 1966 Aug; 42(16):1058-60. PubMed ID: 5969468
    [No Abstract]   [Full Text] [Related]  

  • 13. The monoiodoacetate (MIA) tolerance test, a new quantitative method for the fibrin stabilizing factor (factor 13) assay.
    Sigg P
    Thromb Diath Haemorrh; 1966 Jan; 15(1):238-51. PubMed ID: 5919804
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorrhagic diathesis caused by a deficiency of the fibrin-stabilizing factor (factor 13)].
    Lechler E; Köhler J
    Verh Dtsch Ges Inn Med; 1968; 74():144-7. PubMed ID: 5714300
    [No Abstract]   [Full Text] [Related]  

  • 15. The fibrin stabilizing factor, factor XIII.
    Duckert F
    Blut; 1973 Mar; 26(3):177-9. PubMed ID: 4571301
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran.
    Eshghi P; Mahjour SB; Naderi M; Dehbozorgian J; Karimi M
    Haemophilia; 2010 Mar; 16(2):383-5. PubMed ID: 19878334
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J; Wang Q; Gao F; He JW; Zhao JH
    J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of p-aminomethylbenzoic acid (PAMBA) on the fibrin stabilizing factor].
    Vogel G; Sundermann A; Richardt M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):77-9. PubMed ID: 4173885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of desmofibrinogenic activity and FSF (factor XIII of blood coagulation) level in plasma of healthy children in various age groups].
    Zuch A; Zwierzowa W; Rudobielska M; Buluk K
    Pediatr Pol; 1972 Oct; 47(10):1205-11. PubMed ID: 5085406
    [No Abstract]   [Full Text] [Related]  

  • 20. [Factor XIII (fibrin stabilizing factor) in cutaneous epitheliomas].
    Argenziano G; Rossi A
    G Ital Dermatol Minerva Dermatol; 1970 Feb; 45(2):69-72. PubMed ID: 5467616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.